Augmentation of anti-cytokine immunotherapy by combining neutralizing monoclonal antibodies to interferon-γ and the interferon-γ receptor: protection in endotoxin shock

Abstract

We have employed neutralizing monoclonal antibodies to mouse interferon-γ (IFNγ) and to the receptor for mouse IFNy in studies designed to assess the protective efficacy of each of these monoclonals, administered either separately or in combination, in endotoxin-induced lethality. While pretreatment with either antibody alone, at doses of 200 μg per mouse, provided limited protection (70-50% lethality) in comparison to non-neutralizing antibody controls (100% lethality), the two monoclonal antibodies administered together provided a substantially greater level of protection (17% lethality). Although administration of 100 μg per mouse of either monoclonal alone was not protective (more than 65% lethality), a combination of both antibodies at this dose provided significant protection (19% lethality). In addition, administration of both antibodies 30 min post-endotoxin challenge also demonstrated significant protection in comparison to single antibody immunotherapy. In vitro studies using mouse peritoneal macrophages stimulated with LPS and IFNy have established confirmatory data for a synergistic effect of neutralizing antibody to IFNy and the IFNγ receptor in inhibiting macrophage activation as assessed by production of nitric oxide. These results provide a strong rationale for dual targeting of ligand and receptor in single cytokine immunotherapy.

Get full access to this article

View all access options for this article.

References

Gerard C. , Bruyns C. , Marchant A. et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993; 177: 547-550.

Redl H. , Schlag G. , Bahrami S. , Schade U. , Ceska M. , Stutz P. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 1991; 164: 383-388.

Shalaby M.R. , Halgunset J. , Haugen O.A. , Aarset H. , Aarden L. , Waage A. Cytokine-associated tissue injury and lethality in mice: a comparative study. Clin Immunol Immunopathol 1992; 61: 69-82.

Chomarat P. , Rissoan M.D. , Banchereau J. , Miossec P. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 1993; 177: 523-527.

Herbert J.M. , Savi P. , Laplace M.C. , Lale A. IL-4 inhibits LPS-, IL-1 beta-, and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 1992; 310(1): 31-33.

Porat R. , Poutsiaka D.D. , Miller L.C. , Granowitz E.V. , Dinarello C.A. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 1992; 6: 2482-2486.

Vellenga E. , Dokter W. , de-Wolf J T , van-de-Vinne B , Esselink M.T. , Halie M.R. Interleukin 4 prevents the induction of G-CSF mRNA in human adherent monocytes in response to endotoxin and IL-1 stimulation. Br J Haematol 1991; 79: 22-26.

Beutler B. , Milsark I.W. , Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science 1985; 229: 869-871.

Doherty G.M. , Lange J.R. , Langstein H.N. , Alexander H.R. , Buresh C.M. , Norton J.A. Evidence for IFNγ as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol 1992; 149: 1666-1670.

10.

Tracey K. , Fong Y. , Hesse D.G. et al Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330: 662-664.

11.

Stames H.F. Jr , Pearce M.K. , Tewari A. , Yim J.H. , Zou J-C. , Abrams J.S. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor- challenge in mice. J Immunol 1990; 145: 4185-4191.

12.

Howard M. , Muchamuel T. , Andrade S. , Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177: 1205-1208.

13.

Bucklin S.E. , Silverstein R. , Morrison D.C. An interleukin-6-induced acute-phase response does not confer protection against lipopolysaccharide lethality. Infect Immun 1993; 61: 3184-3189.

14.

Ashkenazi A. , Marsters S.A. , Capon D.J. et al. Protection against endotoxin shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 1991; 88: 10535-10539.

15.

Wakabayashi G. , Gelfand J.A. , Burke J.F. , Thompson R.C. , Dinarello C.A. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991; 5: 338-342.

16.

McIntyre K.W. , Stepan G.J. , Kolinsky K.D. et al. Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J Exp Med 1991; 173: 931-939.

17.

Cross A.S.

Biotech strategies for treatment of sepsis. Endotoxin

Newsletter 1993; 3(2): 2-3.

18.

Basu M. , Pace J.L. , Pinson D.M. , Russell S.W. A monoclonal antibody against the ligand binding site of the receptor for mouse interferon-y. J Interferon Res 1989; 9: 551-562.

19.

Jarpe M.A. , Hayes M.P. , Russell J.K. , Johnson H.M. , Russell S.W. Causal association of interferon-y with tumor regression. J Interferon Res 1989; 9: 239-244.

20.

Stuehr D.J. , Nathan C.F. Nitric oxide - a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-1555.

21.

Heinzel F.P. The role of IFNy in the pathology of experimental endotoxemia. J Immunol 1990; 145: 2920-2924.

22.

Heremans H. , Damme J.V. , Dillen C. , Dijkmans R. , Billiau A. Interferon-y, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med 1990; 171: 1853-1869.

23.

Gifford G.E. , Matthes L. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J Natl Cancer Inst 1987; 78: 121-124.

24.

Katschinski T. , Galanos C. , Coumbos A. , Freudenberg M.A. Gamma interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect Immun 1992; 60: 1994-2001.

25.

Lehmann V. , Freudenberg M.A. , Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987; 165: 657-663.

26.

Pinson D.M. , LeClaire R D, Lorsbach R B, Parmely M J, Russell S W. Regulation by transforming growth factor-1 of expression and function of the receptor for IFNγ on mouse macrophages. J Immunol 1992; 149: 2028-2034.